Iovance Biotherapeutics, Inc. IOVA Business Segments — Segment Reporting Other Item Amount
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s business segments — segment reporting other item amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s business segments — segment reporting other item amount?
- Iovance Biotherapeutics, Inc. (IOVA) reported business segments — segment reporting other item amount of $8.25M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s business segments — segment reporting other item amount changed year-over-year?
- Iovance Biotherapeutics, Inc.'s business segments — segment reporting other item amount decreased by 46.6% year-over-year, from $15.45M to $8.25M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s business segments — segment reporting other item amount?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s business segments — segment reporting other item amount has grown at a -2.7% compound annual growth rate (CAGR), from $46.1M to $43.61M.
- What does business segments — segment reporting other item amount mean?
- This captures miscellaneous or non-recurring operational items that do not fit into standard expense categories but impact the segment's bottom line. It is used to identify unique operational events or adjustments that may affect period-over-period financial comparability.